ARCHIVES

WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use

This article is from The Cancer Letter archive.

Vol. 28 No. 40 | November 2, 2002

Download PDF Visit The Full Archive

Related Articles

Guidelines Adopted For Pathology Review

February 22, 1980

President Signs Interim Money Bill; NCI At $725 Million

July 4, 1975

Translational Research Needs Coordination, Budget, Advisors Say. Former SWOG Chairman Hoogstraten Publishes Memoir.

June 23, 2006

CHMP Delivers Positive Opinion For Two-Dose HPV Vaccine

February 28, 2014

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

Appeals Court Lifts Injunction On Federal Funding for Stem Cell Research.

September 10, 2010